Breast Cancer Clinical Trials in Richmond, Virginia
14 recruitingRichmond, Virginia
Showing 1–14 of 14 trials
Recruiting
Not Applicable
Cardiac Outcomes With Near-Complete Estrogen Deprivation
Breast Cancer
Duke University90 enrolled3 locationsNCT05309655
Recruiting
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
Breast Cancer
Endomagnetics Ltd.184 enrolled2 locationsNCT06610539
Recruiting
Phase 3
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Stemline Therapeutics, Inc.4,220 enrolled524 locationsNCT06492616
Recruiting
Phase 3
E-Mindfulness Approaches for Living After Breast Cancer
Breast CancerDepression
NRG Oncology402 enrolled277 locationsNCT06748222
Recruiting
Phase 3
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
NRG Oncology3,960 enrolled1209 locationsNCT05879926
Recruiting
Not Applicable
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
Breast CancerCognitive Impairments
NRG Oncology386 enrolled680 locationsNCT05896189
Recruiting
Phase 3
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Breast Cancer
Pfizer1,020 enrolled518 locationsNCT06760637
Recruiting
Phase 1
Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation
Breast Cancer
Virginia Commonwealth University33 enrolled1 locationNCT06966388
Recruiting
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Breast Cancer
Exact Sciences Corporation1,800 enrolled58 locationsNCT06401421
Recruiting
Phase 3
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Breast Cancer
Canadian Cancer Trials Group2,140 enrolled475 locationsNCT03488693
Recruiting
Phase 2
ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
Breast Cancer
Virginia Commonwealth University170 enrolled1 locationNCT06185205
Recruiting
Not Applicable
Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters)
Breast Cancer
Virginia Commonwealth University250 enrolled3 locationsNCT05334732
Recruiting
Phase 2
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)
Breast Cancer
Criterium, Inc.70 enrolled19 locationsNCT04567420
Recruiting
Not Applicable
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Breast CancerBreast Cancer Recurrent
University Health Network, Toronto171 enrolled15 locationsNCT05592938